Bharat Biotech s clarification comes at a time when the country is facing a shortage of COVID-19 vaccines, leading to disruptions in the nationwide inoculation programme.
Bharat Biotech s clarification comes at a time when the country is facing a shortage of COVID-19 vaccines, leading to disruptions in the nationwide inoculation programme.
Bharat Biotech said on Friday that the timeline for manufacturing, testing, and release for a batch of Covaxin is approximately 120 days.In a statement, the company said that manufacturing, testing, release and distribution of vaccines is a .